BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29864117)

  • 1. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    Balogh KN; Templeton DJ; Cross JV
    PLoS One; 2018; 13(6):e0197702. PubMed ID: 29864117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
    Lv W; Chen N; Lin Y; Ma H; Ruan Y; Li Z; Li X; Pan X; Tian X
    Cancer Lett; 2016 Jun; 375(2):245-255. PubMed ID: 26952810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
    Zhang M; Yan L; Kim JA
    Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
    Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
    Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor involvement in breast cancer (Review).
    Richard V; Kindt N; Saussez S
    Int J Oncol; 2015 Nov; 47(5):1627-33. PubMed ID: 26412712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
    Subbannayya T; Leal-Rojas P; Barbhuiya MA; Raja R; Renuse S; Sathe G; Pinto SM; Syed N; Nanjappa V; Patil AH; Garcia P; Sahasrabuddhe NA; Nair B; Guerrero-Preston R; Navani S; Tiwari PK; Santosh V; Sidransky D; Prasad TS; Gowda H; Roa JC; Pandey A; Chatterjee A
    BMC Cancer; 2015 Nov; 15():843. PubMed ID: 26530123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the CTL response by macrophage migration inhibitory factor.
    Abe R; Peng T; Sailors J; Bucala R; Metz CN
    J Immunol; 2001 Jan; 166(2):747-53. PubMed ID: 11145646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite.
    Filbey KJ; Varyani F; Harcus Y; Hewitson JP; Smyth DJ; McSorley HJ; Ivens A; Nylén S; Rottenberg M; Löser S; Maizels RM
    Front Immunol; 2019; 10():2375. PubMed ID: 31708913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
    Wang D; Wang R; Huang A; Fang Z; Wang K; He M; Xia JT; Li W
    Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
    Wang Z; Xue Y; Wang P; Zhu J; Ma J
    Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-γ-mediated skin inflammation.
    Hsieh CY; Chen CL; Lin YS; Yeh TM; Tsai TT; Hong MY; Lin CF
    J Immunol; 2014 Oct; 193(7):3693-703. PubMed ID: 25172501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Macrophage and Dendritic Cell Response in
    Sánchez-Zamora YI; Juarez-Avelar I; Vazquez-Mendoza A; Hiriart M; Rodriguez-Sosa M
    J Diabetes Res; 2016; 2016():7053963. PubMed ID: 27699180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
    Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O
    J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization.
    Das R; LaRose MI; Hergott CB; Leng L; Bucala R; Weiser JN
    J Immunol; 2014 Jul; 193(2):764-72. PubMed ID: 24928996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice.
    Choi S; Kim HR; Leng L; Kang I; Jorgensen WL; Cho CS; Bucala R; Kim WU
    J Immunol; 2012 Oct; 189(8):3905-13. PubMed ID: 22972922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF‑κB/HIF‑1α pathway in lung cancer.
    Li J; Zhang J; Xie F; Peng J; Wu X
    Int J Mol Med; 2018 Feb; 41(2):1062-1068. PubMed ID: 29207023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
    He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
    World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.